Cargando…

Prion protein self-peptides modulate prion interactions and conversion

BACKGROUND: Molecular mechanisms underlying prion agent replication, converting host-encoded cellular prion protein (PrP(C)) into the scrapie associated isoform (PrP(Sc)), are poorly understood. Selective self-interaction between PrP molecules forms a basis underlying the observed differences of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigter, Alan, Priem, Jan, Timmers-Parohi, Drophatie, Langeveld, Jan PM, van Zijderveld, Fred G, Bossers, Alex
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789745/
https://www.ncbi.nlm.nih.gov/pubmed/19943977
http://dx.doi.org/10.1186/1471-2091-10-29
Descripción
Sumario:BACKGROUND: Molecular mechanisms underlying prion agent replication, converting host-encoded cellular prion protein (PrP(C)) into the scrapie associated isoform (PrP(Sc)), are poorly understood. Selective self-interaction between PrP molecules forms a basis underlying the observed differences of the PrP(C )into PrP(Sc )conversion process (agent replication). The importance of previously peptide-scanning mapped ovine PrP self-interaction domains on this conversion was investigated by studying the ability of six of these ovine PrP based peptides to modulate two processes; PrP self-interaction and conversion. RESULTS: Three peptides (octarepeat, binding domain 2 -and C-terminal) were capable of inhibiting self-interaction of PrP in a solid-phase PrP peptide array. Three peptides (N-terminal, binding domain 2, and amyloidogenic motif) modulated prion conversion when added before or after initiation of the prion protein misfolding cyclic amplification (PMCA) reaction using brain homogenates. The C-terminal peptides (core region and C-terminal) only affected conversion (increased PrP(res )formation) when added before mixing PrP(C )and PrP(Sc), whereas the octarepeat peptide only affected conversion when added after this mixing. CONCLUSION: This study identified the putative PrP core binding domain that facilitates the PrP(C)-PrP(Sc )interaction (not conversion), corroborating evidence that the region of PrP containing this domain is important in the species-barrier and/or scrapie susceptibility. The octarepeats can be involved in PrP(C)-PrP(Sc )stabilization, whereas the N-terminal glycosaminoglycan binding motif and the amyloidogenic motif indirectly affected conversion. Binding domain 2 and the C-terminal domain are directly implicated in PrP(C )self-interaction during the conversion process and may prove to be prime targets in new therapeutic strategy development, potentially retaining PrP(C )function. These results emphasize the importance of probable PrP(C)-PrP(C )and required PrP(C)-PrP(Sc )interactions during PrP conversion. All interactions are probably part of the complex process in which polymorphisms and species barriers affect TSE transmission and susceptibility.